Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04337931
Title A Study to Evaluate APX005M in Subjects With Unresectable or Metastatic Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Apexigen, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | ESP

Facility Status City State Zip Country Details
Szpital Kliniczny im. Heliodora Święcickiego UM w Poznaniu Poznan Poland Details
Centrum Onkologii - Instytutu im. Marii Skłodowskiej - Curie w Warszawie Warsaw Poland Details
Hospital Universitario San Juan De Alicante Alicante Spain Details
Hospital Universitari Quirón Dexeus Barcelona Spain Details
Hospital Universitari Vall D'Hebron Barcelona Spain Details
Hospital Universitario Insular De Gran Canaria Las Palmas De Gran Canaria Spain Details
Clínica Universidad De Navarra Sede Madrid Madrid Spain Details
Hospital Clínico San Carlos Madrid Spain Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Hospital Universitario Madrid Sanchinarro Madrid Spain Details
Hospital Clínico Universitario Virgen De La Arrixaca Murcia Spain Details
Hospital Regional Universitario de Málaga Málaga Spain Details
Hospital Universitario Marqués De Valdecilla Santander Spain Details
Hospital Universitario De Canarias Tenerife Spain Details
Consorcio Hospital General Universitario de Valenc Valencia Spain Details
Hospital Universitario Dr. Peset Valencia Spain Details
Instituto Valenciano de Oncología Valencia Spain Details
Complexo Hospitalario Universitario De Vigo Álvaro Cunqueiro Vigo Spain Details
Hospital Universitario Miguel Servet Zaragoza Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field